Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
9.18
+0.02 (0.22%)
Jul 9, 2025, 10:01 AM - Market open
Sage Therapeutics Market Cap
Sage Therapeutics has a market cap or net worth of $574.87 million as of July 9, 2025. Its market cap has decreased by -11.15% in one year.
Market Cap
574.87M
Enterprise Value
161.62M
1-Year Change
-11.15%
Ranking
Category
Stock Price
$9.18
Market Cap Chart
Since July 18, 2014, Sage Therapeutics's market cap has decreased from $751.40M to $574.87M, a decrease of -23.49%. That is a compound annual growth rate of -2.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 574.20M | 72.85% |
| Dec 31, 2024 | 332.20M | -74.44% |
| Dec 29, 2023 | 1.30B | -42.73% |
| Dec 30, 2022 | 2.27B | -9.45% |
| Dec 31, 2021 | 2.51B | -44.34% |
| Dec 31, 2020 | 4.50B | 20.36% |
| Dec 31, 2019 | 3.74B | -16.71% |
| Dec 31, 2018 | 4.49B | -27.36% |
| Dec 29, 2017 | 6.18B | 225.79% |
| Dec 30, 2016 | 1.90B | 12.78% |
| Dec 31, 2015 | 1.68B | 78.25% |
| Dec 31, 2014 | 944.00M | 25.63% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.57B |
| Johnson & Johnson | 376.62B |
| AbbVie | 339.59B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 278.04B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 234.06B |
| AstraZeneca | 216.19B |